The When, What, How, and Why of FDA Engagement with Niki Gallo - The Issue
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
The When, What, How, and Why of FDA Engagement with Niki Gallo - The Issue
-
Narrated by:
-
By:
About this listen
Today, Niki Gallo, principal consultant of regulatory affairs at Halloran Consulting, joins host Emily Walsh Martin for a deep dive into timeline management pitfalls, the nuances of INDs, and the rapidly evolving FDA landscape. Niki brings to the program her extensive experience shepherding innovative therapeutics through the regulatory process and timely insights into the complexities of transitioning from the bench to the bedside.
Whether you’re from industry or academia, today’s conversation will help wrap all our heads around testing novel therapies for the first time in humans.
The ASGCT Annual Meeting is almost here! Join us in New Orleans May 13-17 for the premier event in CGT and save $465 by joining ASGCT and using the incredible discounts the Society provides to members. Visit annualmeeting.asgct.org to check out the full program, plan your trip, and register for the ASGCT Annual Meeting.
Music by: https://www.steven-obrien.net/
--------------------------
Bright New Morning - Steven O'Brien
(Used for free under a Creative Commons Attribution 4.0 License: https://creativecommons.org/licenses/by/4.0/)
Show your support for ASGCT!: https://asgct.org/membership/donate
See omnystudio.com/listener for privacy information.